Beam Therapeutics

BEAM · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$114M

Previous year: $30.1M

+279.5%

EPS

-$0.06

Previous year: -$1.09

Previous year: $28.7M

+12.6%

Total operating expenses

Loading...

Beam Therapeutics

Unlock previous datapoints

Upgrade

Beam Therapeutics

Unlock previous datapoints

Upgrade

Beam Therapeutics Revenue by Segment

Revenue by Segment

License & collaboration Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$2.26B

P/E Ratio

-6.53

Sector

N/A

Industry

N/A

52-Week High

$35.3

52-Week Low

$14.5

R&D expenses

$99.3M

G&A expenses

$32.3M

Total operating expenses

$132M

Change in fair value of derivative liabilities

$50K

Change in fair value of non-controlling equity investments

-$3.33M

Products

Get in Touch

Resources

Beam Therapeutics

Beam Therapeutics

Beam Therapeutics

Beam Therapeutics Revenue by Segment

Revenue by Segment

License & collaboration Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics